Tasmanian Alkaloids to develop new medications from medical cannabis

Johanna Baker-Dowdell
Updated May 18 2017 - 10:17pm, first published 7:31pm
NEW OPPORTUNITIES: Tasmanian Alkaloids to develop new chronic pain medications from medical cannabis.
NEW OPPORTUNITIES: Tasmanian Alkaloids to develop new chronic pain medications from medical cannabis.

The medical cannabis Tasmanian Alkaloids will be growing is destined for chronic pain medication, with products expected within three years.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Johanna Baker-Dowdell

Johanna Baker-Dowdell

Senior journalist

Johanna has more than 22 years experience as a journalist for newspapers, magazines and online publications.

Get the latest Launceston news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.